Image pharmaphorum Editor Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data. Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others. Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency. Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important? Load more results
Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data.
Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others.
Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency.
Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important?
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
